Posts

Showing posts with the label plaques

Amyloid-Beta Structure Revelation Sheds Light on Leqembi’s Function

Image
  Originally p ublished b By Heather McKenzie on May 24, 2023   Pictured: Illustration of amyloid-beta oligomers accumulating into plaques on neurons/iStock, selvanegra In January, the FDA approved Eisai  and Biogen ’s Leqembi (lecanemab) to treat Alzheimer’s disease based on the antibody’s ability to reduce the accumulation of amyloid-beta plaques in the brain. Now, a recently published study has further clarified the drug’s mechanism of action, with potential implications for the future of Alzheimer’s drug development. Antibodies such as Leqembi work by binding to and neutralizing amyloid-beta protein oligomers, free-floating clumps of the amyloid-beta (Aβ) protein. These oligomers further aggregate into the notorious amyloid plaques that are characteristic of Alzheimer’s disease (AD). Original article